News

MedPage Today1dOpinion
A Conversation With FDA Commissioner Marty Makary
Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...
Science-Based Medicine1dOpinion
Goodbye to the Novavax Vaccine? Our Flailing Medical Establishment Rejects Medical Freedom and Refuses to Fund Gold-Standard Science.
Our current Medical Establishment doesn't seem to grasp that they are no longer just Fox News and Twitter celebrities who can ...
BioSpace2d
FDA Alumni, Experts Call on Makary To Stand Up Against Agency’s Politicization
In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...
Becker's Hospital Review2d
Feds ask for new clinical trial for Novavax COVID-19 shot
Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...
Infectious Disease Advisor2d
Novavax COVID-19 Vaccine Moves Closer to Full FDA Approval
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
Novavax: Grandiose Ambitions, Smart Strategy, But FDA Decision Adds To Challenges
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...